Ligand validation:7FL9

VJO: N-(2,3-dihydro-1,4-benzodioxin-6-yl)methanesulfonamide

VJO is a Ligand Of Interest in 7FL9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7FL9_VJO_A_2101	11%	23%	0.262	0.781	1.99	1.23	4	3	1	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.